Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) insider Keith J. Sullivan sold 8,000 shares of the business’s stock in a transaction dated Tuesday, October 4th. The shares were sold at an average price of $38.84, for a total value of $310,720.00. Following the completion of the sale, the insider now directly owns 82,591 shares of the company’s stock, valued at approximately $3,207,834.44. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Shares of Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) opened at 40.22 on Monday. Zeltiq Aesthetics Inc. has a 1-year low of $18.41 and a 1-year high of $41.43. The stock’s 50 day moving average is $38.74 and its 200 day moving average is $31.88. The company has a market cap of $1.59 billion, a P/E ratio of 60.48 and a beta of 0.79.
Zeltiq Aesthetics (NASDAQ:ZLTQ) last issued its quarterly earnings data on Monday, August 8th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.05) by $0.07. Zeltiq Aesthetics had a negative return on equity of 9.90% and a net margin of 9.54%. The business had revenue of $89.50 million for the quarter, compared to analysts’ expectations of $79.68 million. During the same period in the previous year, the business posted $0.03 earnings per share. The company’s revenue for the quarter was up 38.9% on a year-over-year basis. On average, analysts predict that Zeltiq Aesthetics Inc. will post ($0.13) earnings per share for the current year.
A number of hedge funds and other institutional investors have recently modified their holdings of ZLTQ. Texas Permanent School Fund acquired a new position in shares of Zeltiq Aesthetics during the first quarter valued at about $695,000. Nisa Investment Advisors L.L.C. purchased a new stake in Zeltiq Aesthetics during the first quarter valued at approximately $1,575,000. Prudential Financial Inc. purchased a new stake in Zeltiq Aesthetics during the first quarter valued at approximately $2,049,000. BlackRock Group LTD boosted its stake in Zeltiq Aesthetics by 278.1% in the first quarter. BlackRock Group LTD now owns 30,785 shares of the company’s stock valued at $837,000 after buying an additional 22,642 shares during the period. Finally, BlackRock Fund Advisors boosted its stake in Zeltiq Aesthetics by 134.5% in the first quarter. BlackRock Fund Advisors now owns 2,098,036 shares of the company’s stock valued at $56,983,000 after buying an additional 1,203,254 shares during the period.
A number of research firms have weighed in on ZLTQ. Brean Capital reiterated a “buy” rating and set a $35.00 target price on shares of Zeltiq Aesthetics in a report on Tuesday, June 21st. Leerink Swann restated a “buy” rating on shares of Zeltiq Aesthetics in a research note on Thursday, June 30th. Zacks Investment Research downgraded Zeltiq Aesthetics from a “hold” rating to a “sell” rating in a research note on Thursday, July 14th. Maxim Group upped their price target on Zeltiq Aesthetics from $40.00 to $48.00 and gave the stock a “buy” rating in a research note on Tuesday, August 9th. Finally, JPMorgan Chase & Co. restated a “hold” rating and issued a $35.00 price target (up previously from $27.00) on shares of Zeltiq Aesthetics in a research note on Tuesday, August 9th. Three investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $39.89.
About Zeltiq Aesthetics
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.
Receive News & Ratings for Zeltiq Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.